Diaverum is a Swedish-born, multinational healthcare organisation that provides life-enhancing renal care to patients with Chronic Kidney Disease (CKD), empowering them to live fulfilling lives.
Our vision is to transform the industry through patient-centric digital innovations, delivering and broadening access to the highest quality of care.
Our focus is to provide renal care tailored to patients’ needs and choices, offering a portfolio of treatments ranging from preventive care, haemodialysis, peritoneal dialysis and home care, to coordination of patients’ comorbidities and holiday dialysis.
As a global leader and the largest independent renal service provider in Europe, we care for around 40,000 patients across 450 clinics in 24 countries globally. Diaverum employs around 13,000 people worldwide and is headquartered in Malmö, Sweden.
renal care services, renal care, Haemodialysis, Chronic Kidney Disease, Peritoneal dialysis, Transplants, CKD, Holiday dialysis, Life-enchancing renal care, Proprietary Care Delivery Model, Digital Innovation, and True care culture
We are one of the world’s largest renal care provider
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 2 May 2024 | | |
Agence régionale de santé - Provence-Alpes-Côte-d'Azur ( ARS Paca ) | Other 29 Dec 2023 | |